Glycerol kinase 5 confers gefitinib resistance through SREBP1/SCD1 signaling pathway

BACKGROUND: Drug resistance is common in cancer chemotherapy. This study investigates the role of Glycerol kinase 5 (GK5) in mediating gefitinib resistance in NSCLC. METHODS: The exosomal mRNA of GK5 was detected using a tethered cationic lipoplex nanoparticle (TCLN) biochip. Real-time PCR and Weste...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jian, Qu, Guimei, Zhang, Ge, Wu, Zuoren, Liu, Jing, Yang, Dawei, Li, Jing, Chang, Meijia, Zeng, Hengshan, Hu, Jie, Fang, Tao, Song, Yuanlin, Bai, Chunxue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385389/
https://www.ncbi.nlm.nih.gov/pubmed/30791926
http://dx.doi.org/10.1186/s13046-019-1057-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385389/
https://www.ncbi.nlm.nih.gov/pubmed/30791926
http://dx.doi.org/10.1186/s13046-019-1057-7

Ejemplares similares